ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Zaltenibart Biosimilar - Anti-MASP1 Antibody - BSA and Azide free (A340751)

Chimeric monoclonal antibody to MASP1. Research grade Zaltenibart biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 7-10 business days.
Name
Zaltenibart Biosimilar - Anti-MASP1 Antibody - BSA and Azide free
Description
Chimeric monoclonal antibody to MASP1. Research grade Zaltenibart biosimilar.
Applications
ELISA, Flow Cytometry, Functional Studies, in vivo Research
Reactivity
Human
Host
Chimeric
Clonality
Monoclonal
Isotype
IgG4
Conjugate

Unconjugated

Purity
The purity of this Biosimilar is >95%, as determined by SDS-PAGE.
Product Form
Liquid
Formulation
Supplied in 0.01M Phosphate Buffered Saline, pH 7.4.
Storage
Shipped at 4°C. Upon delivery store at 4°C for short-term use (1-2 weeks) or aliquot and store at -20°C for long-term use (up to 12 months).
Synonyms
Complement factor MASP-3, Complement-activating component of Ra-reactive factor, CRARF, CRARF1, Mannan-binding lectin serine protease 1, Mannose-binding lectin-associated serine protease 1, Mannose-binding protein-associated serine protease, MASP-1, PRSS5, Ra-reactive factor serine protease p100, RaRF, Serine protease 5
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Zaltenibart Biosimilar - Anti-MASP1 Antibody - BSA and Azide free (A340751)? Please let us know so that we can list the citation on this page.

Alternative products to Zaltenibart Biosimilar - Anti-MASP1 Antibody - BSA and Azide free (A340751)

Proteins predicted to interact with MASP1

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.8% Relevancy Score
99% Relevancy Score
98.6% Relevancy Score
98% Relevancy Score
94.2% Relevancy Score
93.6% Relevancy Score